Nanalysis Gains Funding for AI Drug Detection Tech

Nanalysis Scientific Corp (TSE:NSCI) has released an update.

Nanalysis Scientific Corp. has secured up to $1.45 million in funding from the National Research Council of Canada to advance AI software for detecting illicit substances with its NMR spectrometers. The project aims to address the growing global challenge of identifying new and known drugs, with potential to revolutionize forensic science and support law enforcement. The AI-enhanced platform will enhance drug analysis and identification, streamlining processes in forensic laboratories.

For further insights into TSE:NSCI stock, check out TipRanks’ Stock Analysis page.